Expanding Xpert MTB/RIF Ultra and lateral flow urine lipoarabinomannan testing for diagnosis of tuberculosis among adults living with HIV admitted to hospitals in Tanzania and Mozambique (EXULTANT): a randomised controlled trial.

Cossa M, Ndege R, Meggi B, Mangu C, Leukes V, Sabi I, Khosa C, Kivuma B, Nguenha D, Riess F, Fernández-Escobar C, de la Torre-Perez L, Manjate P, Weisser M, Machiana A, Zachariah C, Tagliani E, Ehrlich J, Buech J, Schacht C, Sanz S, Singh S, Mnzava D, Schumacher SG, Cox H, Scott L, Ntinginya N, Kranzer K, Ruhwald M, Penn-Nicholson A, Garcia-Basteiro AL, TB-CAPT Consortium

Open source

DOI
10.1016/s1473-3099(26)00133-7
Published
2026 Sep
Container
The Lancet. Infectious diseases
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1473-3099-26-00133-7,
  title = {Expanding Xpert MTB/RIF Ultra and lateral flow urine lipoarabinomannan testing for diagnosis of tuberculosis among adults living with HIV admitted to hospitals in Tanzania and Mozambique (EXULTANT): a randomised controlled trial.},
  author = {Cossa M and Ndege R and Meggi B and Mangu C and Leukes V and Sabi I and Khosa C and Kivuma B and Nguenha D and Riess F and Fernández-Escobar C and de la Torre-Perez L and Manjate P and Weisser M and Machiana A and Zachariah C and Tagliani E and Ehrlich J and Buech J and Schacht C and Sanz S and Singh S and Mnzava D and Schumacher SG and Cox H and Scott L and Ntinginya N and Kranzer K and Ruhwald M and Penn-Nicholson A and Garcia-Basteiro AL and TB-CAPT Consortium},
  year = {2026},
  journal = {The Lancet. Infectious diseases},
  doi = {10.1016/s1473-3099(26)00133-7},
  url = {https://doi.org/10.1016/s1473-3099(26)00133-7}
}

RIS

TY  - JOUR
TI  - Expanding Xpert MTB/RIF Ultra and lateral flow urine lipoarabinomannan testing for diagnosis of tuberculosis among adults living with HIV admitted to hospitals in Tanzania and Mozambique (EXULTANT): a randomised controlled trial.
AU  - Cossa M
AU  - Ndege R
AU  - Meggi B
AU  - Mangu C
AU  - Leukes V
AU  - Sabi I
AU  - Khosa C
AU  - Kivuma B
AU  - Nguenha D
AU  - Riess F
AU  - Fernández-Escobar C
AU  - de la Torre-Perez L
AU  - Manjate P
AU  - Weisser M
AU  - Machiana A
AU  - Zachariah C
AU  - Tagliani E
AU  - Ehrlich J
AU  - Buech J
AU  - Schacht C
AU  - Sanz S
AU  - Singh S
AU  - Mnzava D
AU  - Schumacher SG
AU  - Cox H
AU  - Scott L
AU  - Ntinginya N
AU  - Kranzer K
AU  - Ruhwald M
AU  - Penn-Nicholson A
AU  - Garcia-Basteiro AL
AU  - TB-CAPT Consortium
PY  - 2026
JO  - The Lancet. Infectious diseases
DO  - 10.1016/s1473-3099(26)00133-7
UR  - https://doi.org/10.1016/s1473-3099(26)00133-7
ER  - 

APA

M, C., R, N., B, M., C, M., V, L., I, S., C, K., B, K., D, N., F, R., C, F., L, D. L. T., P, M., M, W., A, M., C, Z., E, T., J, E., J, B., C, S., S, S., S, S., D, M., SG, S., H, C., L, S., N, N., K, K., M, R., A, P., AL, G., & Consortium, T. (2026). Expanding Xpert MTB/RIF Ultra and lateral flow urine lipoarabinomannan testing for diagnosis of tuberculosis among adults living with HIV admitted to hospitals in Tanzania and Mozambique (EXULTANT): a randomised controlled trial.. The Lancet. Infectious diseases. https://doi.org/10.1016/s1473-3099(26)00133-7

Source records